SINT · Sintx Technologies, Inc. · Executive Compensation
$2.30
+0.07 (+3.14%)
At close · Oct 1
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Despite the actions undertaken by management to improve liquidity and operating costs—including the divestiture of non-core operations, implementation of cost and pricing improvement initiatives, commercialization of newly cleared medical products, access to capital through the Company’s ATM program, and execution of the Armor facility sublease—management has concluded that substantial doubt remains regarding the Company’s ability to continue as a going concern for a period of at least 12 months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 11, 2026
Market Cap
$12.53M
Shares
6.66M
Volume · Sep 30
79.44K
Avg daily vol (3M)
99.24K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| B. Sonny Bal | Chief Executive Officer | $440,651 |
| David O’Brien | Chief Operating Officer | $369,824 |
| Eric Olson | Chief Executive Officer | $194,594 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| B. Sonny Bal | Chief Executive Officer | $537,312 |
| David O’Brien | Chief Operating Officer | $453,602 |
| Eric Olson | Chief Executive Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| B. Sonny Bal | Chief Executive Officer | $511,784 |
| David O’Brien | Chief Operating Officer | $391,903 |
| Bryan J. McEntire | Chief Scientific Officer | $9,283 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| B. Sonny Bal | Chief Executive Officer | $483,087 |
| David O’Brien | Chief Operating Officer | $370,219 |
| Bryan J. McEntire | Chief Scientific Officer | $312,060 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| B. Sonny Bal | Chief Executive Officer | $487,442 |
| David O’Brien | Chief Operating Officer | $346,207 |
| Bryan J. McEntire | Chief Scientific Officer | $297,673 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| B. Sonny Bal | Chief Executive Officer | $401,231 |
| Bryan J. McEntire | Chief Scientific Officer | $249,313 |
| David O’Brien | Chief Operating Officer | $242,152 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| B. Sonny Bal | Chief Executive Officer | $411,693 |
| Bryan J. McEntire | Chief Scientific Officer | $244,357 |
| David O’Brien | Chief Operating Officer | $226,588 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ryan Elmore | President | Appointed | 2026-02-18 |
| Eric Olson | President | Resigned | 2026-02-18 |
| Kevin Trask | Chief Financial Officer | Appointed | 2025-09-05 |
| Mark Froimson | director | Resigned | 2025-04-08 |
| David Truetzel | director | Resigned | 2025-04-08 |
| Jeffrey White | director | Resigned | 2025-04-08 |
| Eric Stookey | director | Resigned | 2025-04-08 |
| B. Sonny Bal | director | Resigned | 2025-04-08 |
| Gregg Honigblum | Director | Appointed | 2025-04-08 |
| Mark Anderson | Director | Appointed | 2025-04-08 |
| Chris Lyons | Director | Appointed | 2025-04-08 |
| Robert D. Mitchell | Director | Appointed | 2025-04-08 |
| Jay M. Moyes | Director | Appointed | 2025-04-08 |
| Eric K. Olson | Chairman of the Board of Directors | Appointed | 2025-03-13 |
| Eric K. Olson | Board of Directors | Appointed | 2024-11-29 |
| Gregg Honigblum | Chief Strategy Officer | Appointed | 2024-11-19 |
| B. Sonny Bal | Chief Executive Officer and President | Retired | 2024-08-06 |
| Eric K. Olson | Chief Executive Officer and President | Appointed | 2024-08-06 |
| B. Sonny Bal, MD | President and Chief Executive Officer | Retired | 2024-04-30 |